首页 | 本学科首页   官方微博 | 高级检索  
检索        

小分子干扰RNA抑制TNC基因的表达并逆转卵巢癌紫杉醇耐药
引用本文:樊蓓,李红霞,吴玉梅,徐小红,邓小虹.小分子干扰RNA抑制TNC基因的表达并逆转卵巢癌紫杉醇耐药[J].癌症进展,2017,15(7).
作者姓名:樊蓓  李红霞  吴玉梅  徐小红  邓小虹
作者单位:首都医科大学附属北京妇产医院妇瘤科,北京,100006;首都医科大学附属北京世纪坛医院妇产科,北京,100038
基金项目:首都医科大学基础临床合作研究基金
摘    要:目的 研究小分子干扰RNA(siRNA)介导的RNA干扰(RNAi)对卵巢癌紫杉醇耐药细胞TNC基因表达的影响,探讨TNC基因在紫杉醇耐药中的功能.方法 用脂质体转染剂LipofectamineTM2000将针对TNC基因特异性合成的siRNA转染SKOV3/TAX30细胞,分别在转染后24、48、72 h收集细胞,检测各组细胞TNC mRNA和TNC蛋白的表达水平.siRNA转染SKOV3/TAX30细胞后,采用MTT法检测细胞对紫杉醇的半数抑制浓度(IC50).Western Blot检测SKOV3/TAX30及SKOV3/TAX300两种耐药细胞Wnt信号通路中关键蛋白β-catenin及下游Cyclin D、E-cadherin蛋白的表达.结果 siRNA转染SKOV3/TAX30细胞24、48、72 h后,TNC mRNA和TNC蛋白表达水平均下降,SKOV3/TAX30细胞对紫杉醇药物的IC50下降.TNC表达升高的耐药细胞中,Wnt信号通路中关键蛋白β-catenin及下游Cyclin D蛋白表达上调,E-cadherin蛋白表达下调.结论 针对TNC基因特异性合成的siRNA可激发RNAi介导的TNC沉默,并且逆转了紫杉醇化疗耐药,TNC表达上调与紫杉醇耐药相关,TNC可能通过Wnt信号通路的激活参与了化疗耐药.

关 键 词:siRNA  卵巢癌  耐药  Tenascin-C

Inhibition of TNC gene expression and reversal of drug resistance via small interference RNA in paclitaxel resistant cell line
FAN Bei,LI Hongxia,WU Yumei,XU Xiaohong,DENG Xiaohong.Inhibition of TNC gene expression and reversal of drug resistance via small interference RNA in paclitaxel resistant cell line[J].Oncology Progress,2017,15(7).
Authors:FAN Bei  LI Hongxia  WU Yumei  XU Xiaohong  DENG Xiaohong
Abstract:Objective To study the effect of small interference RNA (siRNA)-mediated RNAi on TNC gene expres-sion and to explore the function of the TNC gene in paclitaxel resistant cells. Method Specifically synthetic siRNA was transfected into SKOV3/TAX30 cells using LipofectamineTM2000. Cells were collected at 24, 48 and 72 h after transfec-tion. TNC mRNA and TNC protein expression in cells were measured. IC50 of paclitaxel resistant cells was measured us-ing MTT assay. The expression of the critical proteinβ-catenin and the downstream proteins Cyclin D and E-cadherin in the Wnt signaling pathway was measured using Western Blot in SKOV3/TAX30 and SKOV3/TAX300 cells. Result In 24, 48 and 72 h after the transfection of synthetic siRNA into SKOV3/TAX30 cells, the TNC gene demonstrated de-creased mRNA and protein levels. SKOV3/TAX30 cells demonstrated reduced IC50 in paclitaxel resistant cells. Among drug resistant cells that had overexpressed TNC, the level ofβ-catenin and Cyclin D increased while the level of E-cad-herin decreased. Conclusion Synthetic siRNA can be applied to activate the silence of the RNAi-mediated TNC gene and reverse chemo-resistance. Overexpression of TNC was related to paclitaxel resistance of ovarian cancer cells. TNC may modulate drug resistance by activating the Wnt signaling pathway.
Keywords:siRNA  ovarian cancer  drug resistance  Tenascin-C
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号